Medtronic announced today that it selected "MiniMed" as the name for its Diabetes unit following its planned separation.

Medtronic has landed on a new brand for the planned spinout of its diabetes division, and it didn’t have to look very far. | ...

Medtronic plc a global leader in medical technology, announced its intent to spin off its Diabetes business into a entity ...

Medtronic's diabetes care unit has grown faster than the rest of its business in recent years. Over the past few years, Medtronic (NYSE: MDT) has faced significant challenges, including a ...

Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, consumer-oriented segment of its business, while also giving the diabetes unit more ...

The new diabetes company would be the only one in the market that sells both insulin pumps and glucose sensors ... Medtronic is working on its next-generation pump, the MiniMed Flex, and plans to ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter (Q4) and fiscal year 2025 (FY25), which ended April 25, 2025.

The U.S. commercial rollout enabling its use with the MiniMed 780G pump is slated for this fall. Meanwhile, last November, Medtronic secured a clearance for its smart insulin pen app, designed for ...

it comes after a period of recovery when its MiniMed insulin pumps suffered product safety issues that sparked a warning from the Food and Drug Administration, and led to a delay in FDA clearance of ...

Medtronic said Wednesday that it plans to spin off its diabetes business in the next 18 months, creating a new diabetes technology company that can offer customers both insulin pumps and continuous ...